Purpose/Objective: Two types of dosimetric effects due to intrafractional organ motion has been defined; A) the dose-'blurring' or 'smearing' effect, where the dose delivered to a point in the patient is smeared by the motion of this point in the radiation beam, and B) the interplay effect, where the relative motion between the dynamic MLC leaves and the treatment region may lead to a more complicated dosimetric effect. The aim of this study was to investigate any potential breathing interplay effects during VMAT using 3D polymer gel measurements and compare this with the measurement uncertainty. Materials and Methods: To simulate tumour movement caused by respiratory motion, the gel phantoms were positioned on a programmable motion platform (Standard Imaging, Inc), which was set to carry out sinusoidal motion. Two different VMAT (RapidArc®, Varian Medical Systems) plans were delivered; a 6 MV small target plan and a 18MV larger target plan. Each delivery was carried out both to a stationary polymer gel phantom and to a gel phantom during motion with a peak-to-peak distance of 20 mm during a period of 4 s and 5 s, respectively. In order to evaluate the dosimetric impact of the interplay between the phantom motion and the dynamic treatment delivery, we defined the dosimetric interplay effect as the relative 3D absorbed dose difference between the volumes obtained from the VMAT measurement during phantom motion and the VMAT measurement to a stationary phantom convolved with the motion function of the moving platform. Results: The total dosimetric effect of motion was evaluated, i.e. the dose difference between the volume obtained from the measurement during phantom motion and the measurement to a stationary phantom. The isodose volume ≥ 90% was investigated. The mean value and standard deviation of the differences obtained from the measurements were (-3.7±2.6)% for the small target plan and (-4.3±4.8)% for the larger target plan. Investigating the interplay effect, the relative dose difference between the measured VMAT delivery during phantom motion and the convolved stationary VMAT delivery resulted in (-1.2± 1.4)% and (0.9±2.3)% for the small and larger plan, respectively. The results were compared to the dose difference between two repeated stationary convolved gel measurement, which resulted in (0.06±0.5)% and (0.4±0.9)% for the small and larger plan respectively. Although the interplay effects were small compared to the smearing effect, the standard deviations were significantly (p<0.001) larger than the narrow distribution for repeated stationary measurement. Conclusions: The total dosimetric effect due to target motion and dynamic MLC motion during VMAT delivery resulted in an average of about 4% target dose reduction. Comparing with the convolved stationary measurement, which includes only the smoothing effect, the average difference was decreased to around 1%, and the remaining deviation was attributed to interplay effects.
planning based on a class solution for offline (dedicated MR outside of the treatment room) or even online (MR-Linac) adaptation. Materials and Methods: For 10 cervical cancer patients 1 initial CT and MR as well as 4 weekly MRs were available. On those 50 T2weighted transversal MR scans OAR (bladder, rectum and small bowel) as well as target structures (primary, nodal CTV) were manually contoured by an experienced radiation oncologist. Assuming a plan adaptation concept PTVs with 4mm uniform margin were created. The weekly MRs with their respective structure sets were rigidly registered to the CT based on bony anatomy. Treatment plans were generated using 7 beams (6MV) equally distributed around the patient. For each angle beamlets were calculated for a projected area, which contained the PTVs plus a margin of 4mm. The dose calculation was performed with a GPU-based Monte Carlo code (GPUMCD) using the CT data. GPUMCD enables dose calculation in the absence (0T) and presence of a magnetic field (1.5T). The beamlet weights were determined by the fast inverse dose optimization (FIDO) using a class solution for the constraints of target (prescription dose of45Gy) and OAR structures. Dose constraints for the OAR were chosen to be very demanding and are beyond most criteria mentioned in current clinical studies (e.g. RTOG 0418 or INTERTECC study). Target coverage, OAR sparing and timing issues were analyzed. Results: 100 plans (1 initial and 4 weekly plans for 10 patients with and without a magnetic field) were generated and all fulfilled the ICRU criterion for targets, e.g. D95>42.75Gy. The dose distributions in the targets were very homogeneous with a mean D1cc of 48.2Gy. Only 5 plans had a D40>40Gy for the bladder (see Fig. 1 -also for rectum and bowel values). For the rectum 30% of the plans had a D50>30Gy. This was mainly the case when the rectum was empty and closely attached to the primary target. In general the D50 for the rectum was not above 35Gy. For the small bowel 4 plans show a D50 above 30Gy. No significant difference between 0T and 1.5T plans could be identified. Assuming the use of one GPU per beam anautomated plan generation within 2 or 5 minutes (0 or 1.5T) could be shown.
Conclusions:
With the current setting automated plans were generated which mostly fulfilled planning criterion. In few cases with insufficient OAR sparing small adaptions of the weight factors for the planning constraints led to acceptable plans. Fast, automated plan generation for cervical cancer using a class solution is possible. Further research will focus on fast, automated contour propagation. 
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Purpose/Objective: To develop a marker based adaptation strategy, the fluence adaptation of Mohan et al. 1 , is combined with a non-MU preserving step taking into account tumor depth and heterogeneities. Materials and Methods: The adaptation has a geometric and a dosimetric step. The geometric step contains: · A rigid jaw translation using the average detected marker displacement in the BEV. The field sizes and consequently the MU are preserved.
2nd ESTRO Forum 2013 S323 · A thin plate spline deformation, adapting the original fluence 0 into fluence X . In contrast to Ref. 1 marker positions are used instead of organ contours. · An adapted leaf motion, calculated in Eclipse (Varian Medical Systems, Palo Alto, CA). For the dosimetric step ray tracing 5 is used to calculate the radiological path length d, from the source to each marker. Next, the tissue to phantom ratio, TPR(0 .5,d) , is calculated using a fixed 0.5cm field size. The TPR planX / TPR plan0 -median over the different markers rescales the number of monitor units of each beam. For validation a 5 beam sliding window IMRT plan is optimized for the TG119 prostate structures 2 . The phantom is extended with 4 markers and bony anatomy. The initial plan 0 delivers 77Gy(2.2Gy/Fr). Fractions are simulated by applying translations and isotropic scaling using literature values ( Table 1 ). The isotropic expansion is derived from the shrinkage factor, and is used to evaluate the robustness of our approach.
Type
Magnitude (-9.0, 14.9, -13.4) S1 Isotropic shrinkage 4 Expansion factor = 0.9 Target + Markers E1 Isotropic expansion 4 Expansion factor = 1.1 Table 1 : Overview of the applied deformations. The type and magnitude are listed in column 2 and 3. Column 4 indicates on which structures the deformations are applied.
Results:
Results are compared to plan 0 and our clinical standard: shifting of the phantom according to the detected marker positions, see Figure 1 . The combination of the geometric and dosimetric adaptation results in an identical target coverage as was intended (plan X = plan 0 ). The geometric adaptation alone reduces target coverage compared to plan 0 (upper left), similar as our clinical practice (upper row, dashed line (left) vs. solid gray line (right)). All translations have similar results. For S1 and E1 a strongly improved conformity is observed for the adaptation compared to the clinical practice (Figure1). The adaptation ensures a stable, better CI 95 compared to our clinical practice for all applied deformations, this indicates better OAR protection. Conclusions: Target coverage, conformity, and as consequence OAR protection is improved by the presented non-MU preserving adaptation.
